Utilising organs from hepatitis C virus PCR‐positive donors in Western Australia

Abstract

We transplanted six solid organs from three hepatitis C virus (HCV) polymerase chain reaction (PCR)‐positive donors during 2018–2023. Recipients were treated with glecaprevir/pibrentasvir or sofosbuvir/velpatasvir for 4–12 weeks, with all six achieving sustained virological response without significant adverse events. As occurs in other jurisdictions, solid organ transplants from HCR PCR‐positive donors can be safely utilised in Australia.